Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast

Virchows Archiv

Volumn 446, Issue 1, 2005, Pages 10-14

  Kuroda, Hajime ^a   Tamaru, Jun Ichi ^a   Sakamoto, Goi ^c   Ohnisi, Kiyoshi ^b   Itoyama, Shinji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Department of Neurology   (Japan)

^c CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

CD56; CD8; Granzyme B; Medullary carcinoma; TIA 1

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; GRANZYME B; PARAFFIN;

ARTICLE; B LYMPHOCYTE; BREAST CARCINOGENESIS; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HOST RESISTANCE; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; LYMPHOCYTIC INFILTRATION; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; STROMA; SUPPRESSOR CELL; T LYMPHOCYTE; TISSUE SECTION; TUMOR CELL;

ANTIGENS, CD3; ANTIGENS, CD8; BREAST NEOPLASMS; CARCINOMA, MEDULLARY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LYMPHOCYTES, TUMOR-INFILTRATING; POLY(A)-BINDING PROTEINS; PROTEINS; RNA-BINDING PROTEINS;

EID: 13144253138     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-004-1143-9     Document Type: Article

References (22)

1. Arien M, Flores L, Elguezbal A, Levowitz BS (1976) Nodal response in medullary carcinoma of the breast. Am J Surg 131:263-266
2. Ben-Ezra J, Sheibani K (1987) Antigenic phenotype of the lymphocytic component of medullary carcinoma of the breast. Cancer 59:2037-2041
3. Bhan AK, DesMarais CL (1983) Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer. J Natl Cancer Inst 71:507-516
4. Bloom HJG, Richardson WW, Filed JR (1970) Host resistance and survival in carcinoma of the breast a study of 104 cases of medullary carcinoma is a series of 1,411 cases of breast cancer followed for 20 years. BMJ 3:181-187
5. Gaffey MJ, Frierson HF, Mills SE, Boyd JC, Zarbo RI, Simpson JF, Gross LK, Weiss LM (1993) Medullary carcinoma of the breast. Identification of lymphocyte subpopulations and their significance. Mod Pathol 6:721-728
6. Gaudin C, Dietrich PY, Robache S, Guillard M, Escudier B, Lacombe MJ, Kumar A, Triebel F, Caignard A (1995) In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma. Cancer Res 55:685-690
7. Georgiannos SN, Renaut A, Goode AW, Sheaff M (2003) The immunophenotype and activation status of the lymphocytic infiltrate in human breast cancers, the role of the major histocompatibility complex in cell-mediated immune mechanisms, and their association with prognostic indicators. Surgery 134:827-834
8. Hudson JM, Castilleja A, Murray JL, Honda T, Kudelka A, Singletary E, Wharton JT, Ioannides CG (1998) Growth and antigen recognition of tumor-infiltrating lymphocytes from human breast cancer. J Interferon Cytokine Res 18:529-536
9. Marrogi AJ, Munshi A, Merogi AJ, Ohadike Y, El-Habashi A, Marrogi OL, Freeman SM (1997) Study of tumor infiltrating lymphocytes and transforming growth factor-beta as prognostic factors in breast carcinoma. Int J Cancer 74:492-501
10. Moore OS, Foote FW (1949) The relatively favorable prognosis of medullary carcinomas of the breast. Cancer 2:635-642
11. O'Mahony AM, O'Sullivan GC, O'Connell J, Cotter TG, Collins JK (1993) An immune suppressive factor derived from esophageal squamous carcinoma induces apoptosis in normal and transformed cells of lymphoid lineage. J Immunol 151:4847-4856
12. Rapin V, Contesso G, Mouriesse H, Bertin F, Lacombe MJ, Piekarski JD, Travagli JP, Gadenne C, Friedman S (1988) Medullary breast carcinoma: a reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 19:2503-2510
13. Reinfuss M, Stelmach A, Mitus J, Rys J, Duda K (1995) Typical medullary carcinoma of the breast: a clinical and pathological analysis of 52 cases. J Surg Oncol 60:89-94
14. Restifo NP, Marincola FM, Kawakami Y, Taubenberger J, Yannelli JR, Rosenberg SA (1996) Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy. J Natl Cancer Inst 88:100-108
15. Ridolfi RL, Rosen PP, Port A, Kinne D, Mike V (1977) Medullary carcinoma of the breast: a clinicopathologic study with 10-year follow up. Cancer 40:1365-1385
16. Shimokawara I, Imamura M, Yamakawa N, Ishii Y, Kikuchi K (1982) Identification of lymphocyte subpopulations in human breast cancer tissue and its significance: an immunoperoxidase study with anti-human T-and B-cell sera. Cancer 49:1456-1464
17. Tanaka H, Hori M, Ohki T (1992) High endothelial venule and immunocomponent cells in typical medullary carcinoma of the breast. Virchows Arch 420:253-261
18. Tamiolakis D, Simopoulos C, Cheva A, Lambropoulou M, Kotini A, Jivannakis T, Papadopoulos N (2002) Immunophenotypic profile of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Fur J Gynaec Oncol 23:433-436
19. Toso JF, Oei C, Oshidari F, Tartaglia J, Paoletti E, Lyerly HK, Talib S, Weinhold KJ (1996) MAGE-1-specific precursor cytotoxic T-lymphocytes present among tumor-infiltrating lymphocytes from a patient with breast cancer: characterization and antigen-specific activation. Cancer Res 56:16-20
20. Wargotz ES, Silverberg SG (1988) Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria. Hum Pathol 19:1340-1346
21. Yakirevich E, Izhak OB, Rennert G, Kovacs ZG, Resnick MB (1999) Cytotoxic phenotype of tumor infiltrating lymphocytes in medullary carcinoma of the breast. Mod Pathol 12:1050-1056
22. Yazawa T, Kamma H, Ogata T (1993) Frequent expression of HLA-DR antigen in medullary carcinoma of the breast. A possible reason for its prominent lymphocytic infiltration and favorable prognosis. Appl Immunohistochem 1:289-296